<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区

          News >World

          Women can't keep breast implants for life: FDA

          2011-06-23 15:15

          Women can't keep breast implants for life: FDA
          A surgeon holds a breast implant for a patient at his clinic in Caracas, November 5, 2009. [Photo/Agencies]

          Women who get silicone breast implants are likely to need additional surgery within 10 years to address complications such as rupturing of the device, US health regulators said on Wednesday.

          The Food and Drug Administration will work to revise safety labels for silicone breast implants after reviewing data from several long-term studies, which also showed that the products had a small link to a rare form of cancer.

          The agency said the studies overall confirmed its decision that implants can be used safely, but noted the conclusions could be limited because some women dropped out.

          "The key point is that breast implants are not lifetime devices," said Jeff Shuren, director of the FDA's Center for Devices and Radiological Health. "The longer you have the implant, the more likely you are to have complications."

          There were almost 400,000 breast enlargement or reconstruction procedures in the United States in 2010, according to the American Society of Plastic Surgeons. That includes silicone and saline implants.

          Up to 70 percent of all women who received surgery due to disease or trauma, and up to 40 percent of those getting an enlargement procedure using silicone, needed another operation within 10 years, post-approval studies showed.

          The FDA approved silicone gel-filled breast implants sold by Allergan and Johnson & Johnson's Mentor unit in 2006. It had banned silicone implants for most US women in 1992 after some complained that the devices leaked and made them chronically ill.

          As a condition of taking the devices to market, both companies were required to conduct post-approval studies of 40,000 women for 10 years, as well as extend smaller pre-approval studies. The FDA considered the companies' results, as well as reports of negative events and scientific literature.

          Localized Complications

          Based on the data, the FDA said most common complications were localized, such as the hardening of the breast area around the implant, rupture or deflation of it, and the need for additional surgeries.

          Other local complications include implant wrinkling, asymmetry, scarring, pain, and infection at the incision site.

          The report also found a small correlation between implants and anaplastic large-cell lymphoma, a form of cancer that affects about 3,000 Americans a year.

          From 1997 to 2010, there were about 60 cases of ALCL reported for women worldwide out of about 5 million to 10 million women who had breast implants, Shuren said.

          "If there's a true association between that cancer and implants, it's very, very rare," he said.

          The FDA said most long-term studies confirmed initial results, and that most risks of implants were well known.

          "Most women reported high levels of satisfaction with their body image and the shape, feel and size of their implants," the FDA report said, adding that they should monitor their breasts for the rest of their lives.

          The agency also cautioned that post-approval study data could be limited because of the low response rates.

          In the large 10-year studies of 80,000 women, Allergan has collected preliminary two-year data for 60 percent of participants, while Mentor has collected three-year data for only 21 percent.

          Diane Zuckerman, president of the advocacy group National Research Center for Women & Families, said the high dropout rates meant the study was not accurate.

          "So many of the women dropped out before the research was completed that it is impossible to say what percentage of women need additional surgery or have health problems five or 10 years after getting breast implants," she said.

          "This raises questions about FDA's reliance on studies required after a product is approved," she added.

          Allergan shares were down 0.9 percent at $82.04 on the New York Stock Exchange, while Johnson & Johnson dipped 0.2 percent to $66.36.

          Related News:

          主站蜘蛛池模板: 国产成AV人片久青草影院| 国产一卡2卡3卡四卡精品国色无边| 最新偷拍一区二区三区| 中文国产不卡一区二区| 久热视频这里只有精品6| 亚洲另类丝袜综合网| 亚洲国产欧美在线看片一国产| 国产精品偷窥熟女精品视频| 国产精品第一页一区二区| 久久精品亚洲精品国产色婷| 亚洲大片中文字幕久久| 一区二区偷拍美女撒尿视频| 天堂mv在线mv免费mv香蕉 | 97久久超碰国产精品2021| 国产免费高清69式视频在线观看| 精品无码国产污污污免费| 成人无码h真人在线网站| 国产亚洲色视频在线| 免费视频欧美无人区码| 亚洲AV无码东方伊甸园| 国内精品无码一区二区三区| free性欧美videos| 1024你懂的国产精品| 中文字幕日韩精品国产| 漂亮的保姆hd完整版免费韩国| 国产精品精品一区二区三| 美女黄网站18禁免费看| 日本japanese 30成熟| 亚洲小说乱欧美另类| 99久久国产精品无码| 色老头亚洲成人免费影院| 色婷婷综合久久久久中文字幕| 少妇人妻在线视频| 亚洲天堂男人天堂女人天堂| 综合偷自拍亚洲乱中文字幕| 亚洲欧美日产综合一区二区三区| 亚洲综合视频一区二区三区| 国语做受对白XXXXX在线| 亚洲肥老太bbw| 国产永久免费高清在线| 色噜噜狠狠色综合成人网|